CAC
Core Alternative Capital’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.4K | Hold |
91
| – | – | 0.01% | 143 |
|
2025
Q1 | $39.6K | Hold |
91
| – | – | 0.01% | 139 |
|
2024
Q4 | $33.6K | Sell |
91
-24
| -21% | -$8.85K | 0.01% | 165 |
|
2024
Q3 | $59.8K | Hold |
115
| – | – | 0.01% | 140 |
|
2024
Q2 | $62.3K | Hold |
115
| – | – | 0.01% | 136 |
|
2024
Q1 | $59.6K | Sell |
115
-31
| -21% | -$16.1K | 0.01% | 137 |
|
2023
Q4 | $69K | Buy |
146
+9
| +7% | +$4.25K | 0.01% | 149 |
|
2023
Q3 | $59.7K | Sell |
137
-9
| -6% | -$3.93K | 0.01% | 174 |
|
2023
Q2 | $64.9K | Sell |
146
-169
| -54% | -$75.2K | 0.01% | 143 |
|
2023
Q1 | $145K | Buy |
315
+27
| +9% | +$12.4K | 0.02% | 103 |
|
2022
Q4 | $148K | Sell |
288
-50
| -15% | -$25.7K | 0.02% | 105 |
|
2022
Q3 | $154K | Buy |
338
+8
| +2% | +$3.65K | 0.02% | 97 |
|
2022
Q2 | $159K | Buy |
330
+20
| +6% | +$9.64K | 0.04% | 106 |
|
2022
Q1 | $152K | Sell |
310
-7,521
| -96% | -$3.69M | 0.04% | 103 |
|
2021
Q4 | $3.63M | Sell |
7,831
-1,422
| -15% | -$659K | 0.73% | 53 |
|
2021
Q3 | $3.45M | Sell |
9,253
-401
| -4% | -$150K | 0.73% | 54 |
|
2021
Q2 | $3.69M | Buy |
9,654
+1,267
| +15% | +$484K | 0.86% | 48 |
|
2021
Q1 | $3.01M | Sell |
8,387
-8,918
| -52% | -$3.2M | 0.86% | 50 |
|
2020
Q4 | $5.56M | Buy |
17,305
+143
| +0.8% | +$45.9K | 1.66% | 35 |
|
2020
Q3 | $4.61M | Sell |
17,162
-2,957
| -15% | -$794K | 1.57% | 42 |
|
2020
Q2 | $5.29M | Sell |
20,119
-159
| -0.8% | -$41.8K | 1.65% | 40 |
|
2020
Q1 | $4.6M | Buy |
20,278
+13,014
| +179% | +$2.95M | 1.61% | 43 |
|
2019
Q4 | $2.19M | Buy |
+7,264
| New | +$2.19M | 2.01% | 37 |
|